BIOA
BioAge Labs Inc.

489
Mkt Cap
$817.93M
Volume
1,147.00
52W High
$24.00
52W Low
$2.88
PE Ratio
-9.27
BIOA Fundamentals
Price
$19.35
Prev Close
$19.59
Open
$19.44
50D MA
$16.68
Beta
1.23
Avg. Volume
1.05M
EPS (Annual)
-$1.98
P/B
2.53
Rev/Employee
$0.00
$138.07
Loading...
Loading...
News
all
press releases
BioAge Labs (NASDAQ:BIOA) Shares Gap Up - Time to Buy?
BioAge Labs (NASDAQ:BIOA) Shares Gap Up - What's Next...
MarketBeat·19h ago
News Placeholder
More News
News Placeholder
BioAge Labs, Inc. (NASDAQ:BIOA) Given Consensus Rating of "Hold" by Analysts
BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) has been assigned an average recommendation of "Hold" from the three analysts that are currently covering the stock, MarketBeat reports. One equities...
MarketBeat·1d ago
News Placeholder
BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Down 16.3% in January
BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) was the target of a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 909,129 shares, a...
MarketBeat·3d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Trading Down 5.6% - Here's What Happened
BioAge Labs (NASDAQ:BIOA) Trading Down 5.6% - Here's Why...
MarketBeat·10d ago
News Placeholder
BLA for subcutaneous formulation of Leqembi designated for Priority Review in China
BLA for subcutaneous formulation of Leqembi designated for Priority Review in China BLA for subcutaneous formulation of Leqembi designated for Priority Review in China PR Newswire STOCKHOLM, Feb. 9...
PR Newswire·10d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Insider Sells $139,368.75 in Stock
BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 7,433 shares of the firm's stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average...
MarketBeat·16d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of BioAge Labs from a "sell" rating to a "hold" rating in a report on Tuesday...
MarketBeat·16d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen lowered shares of BioAge Labs from a "hold" rating to a "sell" rating in a research note on Monday...
MarketBeat·24d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Stock Price Down 4.1% - Here's What Happened
BioAge Labs (NASDAQ:BIOA) Stock Price Down 4.1% - Here's Why...
MarketBeat·28d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Shares Gap Down - Time to Sell?
BioAge Labs (NASDAQ:BIOA) Shares Gap Down - Here's What Happened...
MarketBeat·29d ago
<
1
2
...
>

Latest BIOA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.